All In MedTech

FDA Clearance Tracker · P080015-S009

CERVISTA HPV 16/18

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 29, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080015-S009
Device name
CERVISTA HPV 16/18
Applicant
Hologic, Inc.
Applicant location
Malborough, MA
Received
Jul 31, 2013
Decided
Apr 29, 2014
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P080015

Device type

Device class
Class III

Every decision under product code MAQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A POST APPROVAL STUDY LABELING UPDATE.

Source documents

Other decisions for Hologic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.